IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,325 | +18.0% | 216,782 | +23.3% | 0.13% | -5.8% |
| Q4 2022 | $1,123 | -99.9% | 175,793 | +117.6% | 0.14% | +35.0% |
| Q3 2022 | $774,000 | -60.8% | 80,776 | -54.8% | 0.10% | -65.2% |
| Q2 2022 | $1,972,000 | +604.3% | 178,578 | +961.5% | 0.30% | +678.9% |
| Q1 2022 | $280,000 | -4.8% | 16,823 | +9.3% | 0.04% | +2.7% |
| Q4 2021 | $294,000 | +19.0% | 15,398 | +189.4% | 0.04% | -7.5% |
| Q4 2020 | $247,000 | +81.6% | 5,321 | -62.7% | 0.04% | +185.7% |
| Q1 2019 | $136,000 | -43.1% | 14,266 | -47.2% | 0.01% | -50.0% |
| Q4 2018 | $239,000 | – | 27,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |